Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Adient, a global automotive seating supplier, reported third-quarter 2026 results aligning with internal expectations despite facing external pressures.</li><li>Consolidated revenue increased by 5% year-over-year to approximately $3.9 billion, driven by favorable volume, pricing, and foreign exchange, particularly in the Americas and Asia.</li><li>Adjusted EBITDA remained flat at $225 million, reflecting a margin of 5.7%.</li></ul>

Adient, a global automotive seating supplier, reported third-quarter 2026 results aligning with internal expectations despite facing external pressures.Consolidated revenue increased by 5% year-over-year to approximately $3.9 billion, driven by favorable volume, pricing, and foreign exchange, particularly in the Americas and Asia.Adjusted EBITDA remained flat at $225 million, reflecting a margin of 5.7%.

Adient’s Hidden China Catalyst — NIO, Leapmotor & Nissan Drive New Growth!

Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

<ul>
 <li>Adient is the world's largest automotive seating supplier, holding leading market share positions in North America, Europe, and China, which provides significant scale and deep-rooted customer relationships with major global OEMs.</li>
 <li>The company faces considerable headwinds from the highly cyclical and competitive nature of the auto industry, persistent pricing pressure from OEM customers, and volatility in input costs.</li>
 <li>Financially, Adient exhibits volatile profitability and high leverage, which constrains strategic flexibility. However, it has demonstrated strong free cash flow generation, which management is prioritizing for debt reduction and operational improvements.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  Adient is the world's largest automotive seating supplier, holding leading market share positions in North America, Europe, and China, which provides significant scale and deep-rooted customer relationships with major global OEMs.
  The company faces considerable headwinds from the highly cyclical and competitive nature of the auto industry, persistent pricing pressure from OEM customers, and volatility in input costs.
  Financially, Adient exhibits volatile profitability and high leverage, which constrains strategic flexibility. However, it has demonstrated strong free cash flow generation, which management is prioritizing for debt reduction and operational improvements.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

<ul><li>Adient has moved to deepen its North American seating footprint by acquiring a foam production plant in Romulus, Michigan from Woodbridge, adding an established facility that already supplies foam seating components to multiple automaker customers.</li><li>The transaction includes the building, land, production equipment, inventory and related assets, while current plant employees will transition to Adient and the existing UAW collective bargaining agreement will remain in place.</li><li>The move comes as Adient is raising its FY26 outlook, citing improving production schedules, stronger China growth, onshoring opportunities and resilient execution despite recent customer disruptions.</li></ul>

Adient has moved to deepen its North American seating footprint by acquiring a foam production plant in Romulus, Michigan from Woodbridge, adding an established facility that already supplies foam seating components to multiple automaker customers.The transaction includes the building, land, production equipment, inventory and related assets, while current plant employees will transition to Adient and the existing UAW collective bargaining agreement will remain in place.The move comes as Adient is raising its FY26 outlook, citing improving production schedules, stronger China growth, onshoring opportunities and resilient execution despite recent customer disruptions.

Adient Acquisition Alert: The Real Reason Behind Its Bold Foam Plant Expansion!

<ul><li>Adient's latest financial results reveal both achievements and challenges faced by the company.</li><li>For the fourth quarter of fiscal 2025, Adient reported an adjusted EBITDA margin of 6.1% and a free cash flow of $134 million, bringing the full-year free cash flow to $204 million.</li><li>This is up from the previous guidance, suggesting a successful effort in overcoming some challenging business conditions such as customer volume reductions and tariffs.</li></ul>

Adient's latest financial results reveal both achievements and challenges faced by the company.For the fourth quarter of fiscal 2025, Adient reported an adjusted EBITDA margin of 6.1% and a free cash flow of $134 million, bringing the full-year free cash flow to $204 million.This is up from the previous guidance, suggesting a successful effort in overcoming some challenging business conditions such as customer volume reductions and tariffs.

Adient: China Growth via Domestic OEM Momentum—A Volume Opportunity Despite Mix & Pricing Headwinds!

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

We are beginning to see early signs of rotations back into more risk-on areas of the equity market -- a bullish sign for the broad market. Short-term outperformance and constructive consolidation/bottoming patterns are evident within biotech (IBB, XBI), small- and micro-caps (IWM, IWC), and emerging markets (EEM). This only adds to our positive outlook for the weeks and months ahead; continue to buy pullbacks.

We are beginning to see early signs of rotations back into more risk-on areas of the equity market -- a bullish sign for the broad market. Short-term outperformance and constructive consolidation/bottoming patterns are evident within biotech (IBB, XBI), small- and micro-caps (IWM, IWC), and emerging markets (EEM). This only adds to our positive outlook for the weeks and months ahead; continue to buy pullbacks.

U.S. Equity Strategy: Risk-On Rotations Vs. Weaker Seasonality; Russell 2000, Biotech, EM Improving

United States

Adient plc is a automotive seating supplier that designs, develops, manufactures, and distributes complete seat systems and their various components. The Company provides its products to the global auto industry for use in vans, pick-up trucks and SUV vehicles.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Adient PLC (ADNT US)

Adient’s Hidden China Catalyst — NIO, Leapmotor & Nissan Drive New Growth!

Adient, a global automotive seating supplier, reported third-quarter 2026 results aligning with internal expectations despite facing external...

Baptista Research

Primer: Adient PLC (ADNT US) - Aug 2026

Adient is the world's largest automotive seating supplier, holding leading market share positions in North America, Europe, and China, which...

αSK Primers

Adient Acquisition Alert: The Real Reason Behind Its Bold Foam Plant Expansion!

Adient has moved to deepen its North American seating footprint by acquiring a foam production plant in Romulus, Michigan from Woodbridge, adding...

Baptista Research

Adient: China Growth via Domestic OEM Momentum—A Volume Opportunity Despite Mix & Pricing Headwinds!

Adient's latest financial results reveal both achievements and challenges faced by the company. For the fourth quarter of fiscal 2025, Adient...

Baptista Research

U.S. Equity Strategy: Risk-On Rotations Vs. Weaker Seasonality; Russell 2000, Biotech, EM Improving

We are seeing signs of rotations back into more risk-on areas of the equity market -- a bullish sign for the broad market. Add to biotech, small-...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)